Hsia NY

No ORCID on file · 6 papers in corpus
observational 2026
In vivo (Athens, Greece) ·doi:10.21873/invivo.14347

BACKGROUND/AIM: Pterygium is a common ocular surface disorder with multifactorial etiology involving environmental exposure and immune dysregulation. Interleukin-12 (IL-12), a key immunomodulatory cytokine, has been implicated in inflammati…

observational 2026
In vivo (Athens, Greece) ·doi:10.21873/invivo.14422

BACKGROUND/AIM: Pterygium is a common ocular surface disorder associated with long-term ultraviolet exposure and/or oxidative DNA damage. Accumulated evidence suggests that defects in DNA repair pathways may contribute to pterygium risk. DN…

observational 2026
Cancer genomics & proteomics ·doi:10.21873/cgp.20573

BACKGROUND/AIM: Pterygium is a fibrovascular ocular disease characterized by extracellular matrix (ECM) remodeling. Matrix metalloproteinase-3 (MMP-3), a key ECM-modulating enzyme, has been implicated to involved in pterygium progression, b…

observational 2025
In vivo (Athens, Greece) ·doi:10.21873/invivo.14116

BACKGROUND/AIM: Pterygium is a common ocular surface disorder characterized by abnormal fibrovascular growth and extracellular matrix remodeling, yet its precise molecular etiology remains unclear. Matrix metalloproteinases (MMPs) have been…

observational 2024
In vivo (Athens, Greece) ·doi:10.21873/invivo.13472

BACKGROUND/AIM: In the literature, the studies about the role of matrix metalloproteinase-2 (MMP-2) in pterygium diagnosis are mainly based on its protein expression. The role of MMP-2 variants has never been examined. The aim of this study…

observational 2024
In vivo (Athens, Greece) ·doi:10.21873/invivo.13683

BACKGROUND/AIM: In current literature, there is a notable lack of studies investigating the role of radiation-sensitive protein 51 (RAD-51) in pterygium diagnosis. Nevertheless, reports indicate elevated expression levels of RAD-51 among re…